Gerontology and Geriatric Medicine (Jun 2023)

Influence of Metabolic Syndrome on Small, Dense LDL, and Subclinical Atherosclerosis in Older Subjects

  • Hiroshi Yoshino MD, PhD,
  • Tomoko Matsumoto MD, PhD,
  • Gen Yoshino MD, PhD

DOI
https://doi.org/10.1177/23337214231179847
Journal volume & issue
Vol. 9

Abstract

Read online

Aging is known as one of the important risk factors for coronary artery disease (CAD). We explore whether an association of metabolic syndrome (Met- S ) increases subclinical atherosclerosis among elderly diabetic subjects estimating the plaque score ( PS ) of the carotid artery. A total of 187 subjects were enrolled. Middle-aged and older groups were divided into two groups. T -test and Chi-square test were also employed. Simple regression analysis for the PS was performed with respective risk factors as independent variables. After selection of independent variables, multiple regression analysis was performed to estimated the association of PS and dependent variable of the study. There were significant differences in body mass index (BMI) ( p < .001), HbA1c ( p < .01), TG ( p < .05), and PS ( p < .001) . Multiple regression analysis in middle-aged subjects showed that the determinant of PS were age ( p < .001), BMI ( p = .006), Met- S ( p = .004), and hs-CRP ( p = .019). Multiple regression analysis in older subjects showed that neither age nor Met- S was included as significant determinant of PS . An association of Met- S is an important factor for progression of subclinical atherosclerosis, but it cannot be a significant determinant of PS if the subjects are limited within older group.